Endogenous cannabinoids mediate hypotension after experimental myocardial infarction

Journal of the American College of Cardiology

Volumn 38, Issue 7, 2001, Pages 2048-2054

  Wagner, Jens A ^a   Hu, Kai ^a   Bauersachs, Johann ^a   Karcher, Jan ^a   Wiesler, Martina ^a   Goparaju, Sravan K ^b   Kunos, George ^b   Ertl, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY LIGATION; FEMALE; HEMODYNAMICS; HEMORRHAGIC SHOCK; HYPOTENSION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SURVIVAL RATE; TACHYCARDIA; THROMBOCYTE;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; FEMALE; GLYCERIDES; HYPOTENSION; MYOCARDIAL INFARCTION; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SHOCK, CARDIOGENIC; VASODILATION;

EID: 0035203968     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01671-0     Document Type: Article

References (33)

1. Treatment of myocardial infarction in a coronary care unit: A two-year experience with 250 patients
2. Early revascularizatlon in acute myocardial infarction complicated by cardiogenic shock
3. Cardiovascular effects of endocannabinoids: The plot thickens
4. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
5. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
6. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
7. Molecular characterization of a peripheral receptor for cannabinoids
8. 1 cannabinoid receptors in haemorrhagic shock
9. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
10. 1 cannabinoid receptor in the hypotensive action of anandamide
11. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
12. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
13. 2 receptors
14. Isolation of mononuclear cells and granulocytes from human blood
15. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production
16. Effects of 2-([5-chloro-2-methoxyphenyl]azo)-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and septic shock in rats and rabbits
17. Opioids in myocardial ischaemia: Potentiatiing effects of dynorphin on ischaemic arrhrythmia, bradycardia and cardiogenic shock following coronary artery occlusion in the rat
18. 1 cannabinoid receptors
19. 2+ channel current
20. 1 receptors
21. The microcirculation during endotoxemia
22. Hemorrhagic shock
23. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction
24. Assessment of myocardial injury by serum tumor necrosis factor-alpha measurements in acute myocardial infarction
25. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock
26. The role of macrophages in THC-induced alteration of the cytokine network
27. 1 receptors mediate the vasodilated state in advanced liver cirrhosis
28. Pyrexia, procalcitonine, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation
29. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia
30. Mesenteric vasodilation mediated by endothelial anandamide receptors
31. Carbachol, an acetylchloine receptor agonist, enhances the production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid
32. 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor
33. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock